Expert consensus on the pathological evaluation of neoadjuvant therapy efficacy for non-small cell lung cancer.
10.3760/cma.j.cn112151-20210429-00335
- Collective Name:Expert Committee on Quality Control of Lung Cancer, National Quality Control Center for Cancer
- Publication Type:Journal Article
- MeSH:
Carcinoma, Non-Small-Cell Lung/pathology*;
Consensus;
Humans;
Lung Neoplasms/pathology*;
Neoadjuvant Therapy;
Neoplasm Staging
- From:
Chinese Journal of Pathology
2021;50(9):1002-1007
- CountryChina
- Language:Chinese